TCI utilise des cookies pour personnaliser et améliorer votre expérience utilisateur. En poursuivant votre navigation sur notre site, vous acceptez l'utilisation de cookies. Vous pouvez modifier ou mettre à jour vosparamètres de cookies à tout moment.
Maintenance Notice (4:30 AM - 11:00 AM December 21, 2024): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
1, 2, 3, 4, and 5 are dipeptides containing valine (Val)-citrulline (Cit) and p-aminobenzylalcohol (PAB) moieties. It has been reported that Cathepsin B in the lysosome degrades the peptide bond between Cit-PAB.1) Therefore, a drug conjugate bound covalently with carbamate bonds between PAB and the drug can be synthesized by using the dipeptide as a linker. The drug can be then released by hydrolysis after cleavage of the peptide bond between Cit-PAB. Antibody-drug conjugates (ADCs) in which the N-terminus of Val is bound to an antibody have been developed.2)
References
1)Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer Activity
The prices are subject to change without notice. Please confirm the newest price by our online catalog before placing an order. In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.
Votre session expirera dans 10 minutes. Vous serez redirigé vers la page d'accueil après l'expiration de la session. Veuillez cliquer sur le bouton pour continuer la session à partir de la même page. minute. Vous serez redirigé vers la page d'accueil après l'expiration de la session. Veuillez cliquer sur le bouton pour continuer la session à partir de la même page.